Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway

S Oon, NJ Wilson, I Wicks - Clinical & translational immunology, 2016 - Wiley Online Library
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by
impaired immune tolerance, resulting in the generation of pathogenic autoantibodies and …

Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus

Y Yao, L Richman, BW Higgs… - … : Official Journal of …, 2009 - Wiley Online Library
Abstract Objective Type I interferons (IFNs) play an important role in the pathogenesis of
systemic lupus erythematosus (SLE). This phase Ia trial was undertaken to evaluate the …

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic …

Y Yao, BW Higgs, L Richman, B White… - Arthritis research & …, 2010 - Springer
Type I interferons are implicated in the pathogenesis of systemic lupus erythematosus (SLE).
Type I interferon-inducible mRNAs are widely and concordantly overexpressed in the …

Abnormalities of the type I interferon signaling pathway in lupus autoimmunity

S Gallucci, S Meka, AM Gamero - Cytokine, 2021 - Elsevier
Type I interferons (IFNs), mostly IFNα and IFNβ, and the type I IFN Signature are important in
the pathogenesis of Systemic Lupus Erythematosus (SLE), an autoimmune chronic …

An update on the management of childhood-onset systemic lupus erythematosus

VC Trindade, M Carneiro-Sampaio, E Bonfa, CA Silva - Pediatric Drugs, 2021 - Springer
Childhood-onset systemic lupus erythematosus (cSLE) is a prototype of a multisystemic,
inflammatory, heterogeneous autoimmune condition. This disease is characterized by …